Wagner GM, Lubin BH, Chiu DT-Y
But in the long run, its usually better to put your money toward options that are clinically proven and safe, rather than products that rely on marketing rather than evidence
Challenge: Texas Medicaid only has partial GLP-1 coverage, so many patients will be cash-pay or need help with manufacturer programs
Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis
As the field evolves, its crucial for healthcare leaders and organizations to stay agile, adapt to new trends, and focus on what matters most for patients and providers, namely: GLP1s are now firstline therapies: Adoption has accelerated from just 3% in 2021 to more than 23% in 2025, displacing longstanding generics like metformin